Evoke Pharma Inc reports results for the quarter ended in March - Earnings Summary

Evoke Pharma

15/05/2023 22:38

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted
loss
of 67 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 58 cents per
share.
    * Revenue rose 93.6% to $810.00 thousand from a year ago;
analysts
expected $1.00 million. 
    * Evoke Pharma Inc's reported EPS for the quarter was a loss
of 67
cents​.
    * The mean earnings estimate of analysts had fallen by
about 26.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Evoke Pharma Inc shares had risen by 4.7% this quarter and
lost 25.8% so far this year.
    * The company reported a quarterly loss of $2.24 million.
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 09:38 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.58          -0.67          Missed
 Dec. 31 2022      -0.53          -0.53          Met
 Sep. 30 2022      -0.66          -0.60          Beat
 Jun. 30 2022      -0.60          -0.71          Missed